Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference12 articles.
1. Koren G, Nordeng H, MacLeod S (2013b) Gender differences in drug bioequivalence. Time to rethink practices. Clin Pharmacol Ther 93(3):260–262.
https://doi.org/10.1038/clpt.2012.233
2. European Medicines Agency. Guideline on the investigation of bioequivalence. London, 2′ January 2010. CPMP/EWP/QWP/1401/98 Rev. 1/ Corr **
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf
. (Accessed 29.04.2017).
3. U.S. Department of Health and Human Services, Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Guidance for Industry. Bioavailability and Bioequivalence. Studies for Orally Adminsitered Drug Products - General Considerations. March 2003, revision 1.
http://www.fda.gov/ohrms/dockets/ac/03/briefing/3995B1_07_GFI-BioAvail-BioEquiv.pdf
. (Accessed 29.04.2017)
4. González-Rojano E, Abad-Santos F, Ochoa D, Román M, Marcotegui J, Álvarez C, Gordon J, García-Arieta A (2018) Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets. Br J Clin Pharmacol 84(8):1729–1737.
https://doi.org/10.1111/bcp.13601
5. Chen ML, Lee SC, Ng MJ, Schuirmann DJ, Lesko LJ, Williams RL (2000) Pharmacokinetic analysis of bioequivalence trials: implications for sex-related issues in clinical pharmacology and biopharmaceutics. Clin Pharmacol Ther 68(5):510–521.
https://doi.org/10.1067/mcp.2000.111184.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献